CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
The efficacy of saxagliptin in T2DM patients with non-alccholic fatty liver disease: preliminary data 期刊论文
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 卷号: 65, 期号: 1, 页码: 33-37
作者:  Li, Juan-Juan;  Zhang, Ping;  Fan, Bing;  Guo, Xiu-Li;  Zheng, Zhe-Shu
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/11
Efficacy and safety of sitagliptin in patients with type 2 diabetes mellitus: a meta-analysis 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 卷号: 9, 期号: 6, 页码: 11202-11210
作者:  Zhao, Jun-Yu;  Wang, Hai-Peng;  Wang, Huan-Jun;  Yao, Jin-Ming;  Wu, Xiao-Yun
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/16
Investigating the Contributions of Residues to Dipeptidyl Peptidase-IV Inhibitor Binding by Molecular Dynamics Simulation 期刊论文
LETTERS IN DRUG DESIGN & DISCOVERY, 2014, 卷号: 11, 期号: 7, 页码: 886-893
作者:  Liu, Mengyuan;  Sun, Xun;  Zhao, Xian
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/17
Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease 期刊论文
Diabetes & vascular disease research: official journal of the International Society of Diabetes and Vascular Disease, 2012, 卷号: 9, 期号: 4, 页码: 301-308
作者:  Sun,A.-L.;  Deng,J.-T.;  Guan,G.-J.;  Chen,S.-H.;  Liu,Y.-T.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/23
Discovery of potent dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing substituted [1,2,3]-triazolopiperidines for the treatment of type 2 diabetes 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 卷号: 21, 期号: 6, 页码: 1731-1735
作者:  Shan, Zhenwei;  Peng, Min;  Fan, Houxing;  Lu, Qingtao;  Lu, Peng
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/23
Pharmacokinetics of lipoyl vildagliptin, a novel dipeptidyl peptidase IV inhibitor after oral administration in rats 期刊论文
XENOBIOTICA, 2010, 卷号: 40, 期号: 10, 页码: 707-712
作者:  Wang, X.;  Zhang, D.;  Xu, W.;  Liu, H.;  Wang, W.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/26


©版权所有 ©2017 CSpace - Powered by CSpace